Moneycontrol

Moneycontrol PRO

you are here: HomeNewsBusinessEarningsDRL Q3 EBITDA seen up 103% to Rs 596 cr

SHOW NAMES

Trending Topics

business

DRL Q3 EBITDA seen up 103% to Rs 596 cr

Pharmaceutial firm Dr Reddy's Laboratories is expected to report a profit after tax of Rs 425 crore in the third quarter of FY12, a massive growth of 55.5% as compared to Rs 273 crore in a year ago quarter.

first published: Feb 3, 2012 08:00 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347